Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers.

Purdue and its subsidiaries are pioneers in medical science with a patient-first approach in developing prescription and non-prescription medications. We focus on balancing innovative science with clinically effective, compassionate care.

Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients and caregivers. Purdue’s plan of reorganization will deliver billions in value to communities across the country to fund programs specifically for abatement of the opioid crisis.

Purdue is a pioneer in healthcare, with a patient-first approach in developing medicines. We combine medical science with compassionate care in every phase of drug research and manufacturing.

STAMFORD, Conn., Sept. 30, 2024 – Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED) settings. Researchers are now conducting data …

Purdue Pharma develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. For decades, we have developed medications that manage pain.

Oct 28, 2024 · STAMFORD, Conn., August 7, 2024 – Purdue Pharma L.P. (“Purdue”) announced today that the U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the Zurnai™ (nalmefene injection) Auto-Injector. Zurnai (zur nye) is a single-dose…

Purdue Pharma, a privately held, research-based pharmaceutical company, is taking significant steps to transform and diversify beyond its historic focus on pain medications. We are looking for colleagues who want to build an exciting career and grow with us .

Purdue continues to work tirelessly with creditors to reach a new settlement that delivers billions of dollars of value for opioid abatement and allows the Company to emerge from bankruptcy as a company with a public-minded mission.

Oct 28, 2024 · Purdue Pharma distributes, for no profit, nalmefene injection in a 2mg/2mL (1mg/1mL) vial, as part of the Company’s commitment to providing opioid overdose treatments that can help save lives in communities across the country.